Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
12,602,491
-
Share change
-
+12,587,371
-
Total reported value
-
$134,287,000
-
Price per share
-
$10.48
-
Number of holders
-
20
-
Value change
-
+$134,117,000
-
Number of buys
-
19
Institutional Holders of NABRIVA THERAPEUTICS PLC - SHS as of Q2 2017
As of 30 Jun 2017,
NABRIVA THERAPEUTICS PLC - SHS was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,602,491 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Novo Holdings A/S, WELLINGTON MANAGEMENT GROUP LLP, Omega Fund Management, LLC, ACUTA CAPITAL PARTNERS, LLC, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, EcoR1 Capital, LLC, and Nationwide Fund Advisors.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.